Unlike GLP-1 agonists, BPC-157 is not a hormone mimic
Letting the water run gently down the glass wall preserves the molecular integrity that makes the peptide effective
Inflammatory Back Conditions Conditions characterized primarily by inflammation, including facet joint irritation and early-stage disc degeneration, represent good candidates for BPC-157 therapy
SE Salem, OR 97302 Get Directions Hillsboro Clinic 256 SE 2nd Avenue Hillsboro, OR 97123 Get Directions M-Th 8:00AM-6:00PM F 9:00AM-5:00PM All three of our clinic locations are designated as Tier 5 Patient Centered Primary Care Homes (PCPCH) through the Oregon Health Authority (OHA)
These are brand-asserted statements, not independent rankings, lab-verified claims, or endorsements by this publication
Neither peptide has received regulatory approval as a therapeutic agent from the FDA, EMA, or other major regulatory bodies